The cost of medications containing emtricitabine, rilpivirine, and tenofovir can vary significantly depending on factors such as the specific brand, dosage, insurance coverage, and pharmacy. These medications are often prescribed in fixed-dose combinations for the treatment of HIV.
What are common brand names for emtricitabine, rilpivirine, and tenofovir?
One prominent brand name for a combination containing emtricitabine, rilpivirine, and tenofovir alafenamide is Odefsey [1]. Another widely used combination that includes emtricitabine and tenofovir disoproxil fumarate, and is often used with rilpivirine in separate pills, is Truvada.
How much does Odefsey typically cost?
Without insurance, the retail price for a 30-day supply of Odefsey can range from approximately $2,500 to over $3,000 [2]. This price can be lower with discount cards or patient assistance programs.
What are the costs of generic alternatives?
Generic versions of individual components like emtricitabine and tenofovir are available, which can reduce overall treatment costs if a physician prescribes a multi-pill regimen. However, fixed-dose combination generics that precisely match the emtricitabine, rilpivirine, and tenofovir formulation are not yet widely available. The cost of generic emtricitabine alone can be under $100 for a 30-day supply, and generic tenofovir disoproxil fumarate can be similarly affordable, though prices fluctuate [3].
How does insurance affect the price?
Insurance coverage plays a crucial role in the out-of-pocket cost. Many insurance plans cover Odefsey or similar regimens, often with a copay that is substantially less than the full retail price. The specific copay amount depends on the insurance plan's formulary and the patient's benefit design. Some plans may require prior authorization or place the medication in a higher cost-sharing tier.
Are there patient assistance programs available?
Yes, manufacturers often offer patient assistance programs for their medications. For Odefsey, Gilead Sciences provides a patient assistance program that may help eligible individuals who are uninsured or underinsured afford their medication [1]. These programs can significantly reduce the cost for those who qualify.
When do patents for these drugs expire?
The patent landscape for HIV medications is complex, with multiple patents covering different aspects of the drug, its formulation, and its use. Information on specific patent expiry dates for drugs like Odefsey is available through resources that track pharmaceutical patents. For instance, DrugPatentWatch.com lists and analyzes patent information for many drugs, including those used in HIV treatment [4]. This information is critical for understanding when generic competition might emerge.